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The Expanding Frontier in Valve Imaging
Thomas H. Marwick, MBBS, PHD, MPH,* Jagat Narula, MD, PHD†lthough widely used for a multitude of indi-
cations, cardiovascular imaging plays a crit-
ical and irreplaceable role in the assess-
ment of valvular heart disease. In many
previous editorials, we have commented about the
value of using multiple imaging modalities to
gather critically important information for decision-
making, but at the same time maintaining an aware-
ness of the risk of duplication and waste. In this is-
sue of iJACC, we have been fortunate to assemble a
spectrum of research papers that emphasize the role
of imaging in pre-operative evaluation of valvular
heart disease, procedural and operative planning,
and in post-operative evaluation.
Clearly, much of imaging valvular heart disease
focuses on valvular pathology, both anatomically
and functionally. In some situations, our current
algorithms for understanding the severity of valve
stenosis appear to be limited. One such example
of this relates to the recognition of paradoxical
low-flow–low-gradient aortic stenosis (1). A po-
tential approach, proposed by Clavel et al. (2), in-
volves the calculation of projected aortic valve area
from stress echocardiography to define the sever-
ity of aortic stenosis. However, the use of imaging
should not be restricted to overt disease. The use
of 3-dimensional imaging with computational
simulation may provide the ability to understand
leaflet stress, such an approach is not only poten-
tially helpful in the planning of potential inter-
ventions (3) but also in the early recognition of
disease.
Nonetheless, the main focus of new approaches
to valvular disease relate not to the valve, but to
the left ventricle and aorta. Aortopathy is widely
recognized as part of the bicuspid aortic valve
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†Mount Sinai Hospital, New York, New York.phenotype, and Kang et al. (4) have linked the
likelihood of aortopathy to the morphology of bi-
cuspid valve. Given the frequency of bicuspid aor-
tic valve in the population, this information may
be of value in creating decision algorithms for
tracking aortic size with computed tomography
(CT) in selected rather than all patients.
The critical role of left ventricular dysfunction
in mitral valve disease is widely understood, but
the exact mechanism of ischemic mitral regurgita-
tion remains a matter of debate. In an evaluation
of the relative role of papillary muscle infarction
and lateral wall injury using late-enhancement
cardiac magnetic resonance (5), and the extent of
lateral wall injury appeared to be the strongest
correlate of ischemic mitral regurgitation. The na-
ture of left ventricular response in aortic valve dis-
ease is also extremely important. Park et al. (6)
emphasize the association of left ventricular hy-
pertrophy, small left ventricular cavity size, and
diastolic dysfunction with the onset of dyspnea in
patients with aortic stenosis. Similarly, Capoulade
et al. (7) have confirmed insulin resistance as an
associate of left ventricular hypertrophy progres-
sion in patients with aortic stenosis. This infor-
mation builds on a literature concerning the con-
tribution of insulin resistance to nonvalvular left
ventricular hypertrophy, and reinforces the impor-
tance of the metabolic syndrome as a potential
target in patients with aortic stenosis.
Cardiovascular imaging also has an essential
role in planning of valve surgery and percutaneous
interventions. In the planning process for percuta-
neous aortic valve surgery, over-estimation of an-
nular size may lead to valve rupture or other me-
chanical injury related to overinflation. In contrast,
insertion of too small a prosthesis, due to under-
estimation of valve size may lead to aortic regur-
gitation, which is known to be prognostically ad-
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282versorial. Three communications in this issue
emphasize the use of CT for annulus sizing from
double oblique multi layer reconstructions based
upon the line of the perpendicularity assessed
from CT (8-10). Nonetheless, CT may not be
critical for this purpose, and Kasel et al. (11) have
proposed a fluoroscopic approach following the
location of the right coronary cusp in order to op-
timize the position of the C-arm during percuta-
neous intervention. The use of imaging for guid-
ance of aortic valve interventions should not be
restricted to percutaneous interventions. Loor et
al. (12) emphasize that variations in valve position
may influence the success of minimally invasive
surgery, and emphasize the potential role of im-
aging in guiding decisions regarding upper and
lower sternotomy, as well as potential right inter-
costal approaches for valve surgery.
Post-operative valve dysfunction may not be
symptomatic until late in the course of disease. A
common problem is the evaluation of the patient
with an increased gradient across a prosthetic
valve, which may be seen from situations that in-
crease stroke volume or ejection rate such as ane-
mia or anxiety, patient–prosthesis mismatch, andpact of infarct distribution on mitral
1
Automated 3Ddemonstrated that not only is the magnitude of
the gradient important in understanding the like-
lihood of obstruction, but also the nature of the
flow waveform. These investigators identified the
difference between expected and observed valve
area, acceleration time, and the ratio between ac-
celeration and ejection time as potential guides
for the presence of prosthetic valve obstruction.
One of the feared complications of valve replace-
ment is valve thrombosis, which is readily recog-
nized using transesophageal echocardiography. Öz-
kan et al. (14) emphasize the heterogeneity in the
type, dose, and route of administration of throm-
bolytic agents for prosthetic valve thrombosis. In
an observational study, lower dose, transesophageal
echo-guided, repetitive slow administration of lytic
agents was found to be the most efficacious.
In an environment where cost and utility of im-
aging is under question, valvular heart disease re-
mains an area in which imaging is invaluable, and
advanced imaging is readily justifiable. The editors
commend the contributors to this special issue for
lighting the way for new imaging applications to
improve decision-making in the advanced manage-valvular obstruction. Muratori et al. (13) have ment of this increasingly important subject.1
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